Results 231 to 240 of about 1,715,159 (359)
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto+2 more
wiley +1 more source
Fibroblast growth factor 21: update on genetics and molecular biology. [PDF]
Barros DR, Hegele RA.
europepmc +1 more source
Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration
Maya E Woodbury, T. Ikezu
semanticscholar +1 more source
The study introduces innovative 3D microtissues that replicate the glomerular filtration barrier of the kidney, offering a novel platform for understanding podocytopathies. These microtissues simulate the glomerulus's structure and dynamics, allowing for the modeling of podocyte injuries and drug testing.
Sara Buttό+5 more
wiley +1 more source
Excess fibroblast growth factor 23 in alcoholic osteomalacia is derived from the bone. [PDF]
Hidaka N+21 more
europepmc +1 more source
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq+4 more
wiley +1 more source